New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis

<b>Background:</b> Histone deacetylases (HDACs) are critical epigenetic modulators involved in regulating various molecular mechanisms essential for cell development and growth. Alterations in HDAC activity have been linked to the progression of numerous cancers, including lymphoma. Over the past de...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Pavel Spirin, Valeria Vedernikova, Tatsiana Volkava, Alexey Morozov, Alla Kleymenova, Anastasia Zemskaya, Lena Shyrokova, Yuri Porozov, Ksenia Glumakova, Timofey Lebedev, Maxim Kozlov, Vladimir Prassolov
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2025-03-01
Serie:	Pharmaceutics
Soggetti:	epigenetic HDACs belinostat lymphoma leukemia apoptosis
Accesso online:	https://www.mdpi.com/1999-4923/17/4/416
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!